Bacteriostatic activity of serum against staphylococci.
Cybulska, Janina (State Institute of Hygiene, Warsaw, Poland), and J. Jeljaszewicz. Bacteriostatic activity of serum against staphylococci. J. Bacteriol. 91:953-962. 1966.-Antistaphylococcal activity of normal serum against strains exhibiting various patterns of coagulase, clumping-factor, and staphylokinase production is not connected with the presence of these factors. Purified coagulase does not influence this property of serum. Coagulase-negative strains with clumping-factor activity grow in normal serum as typical pathogenic staphylococci. Serum bacteriostatic activity against staphylococci may be reversed by several nonspecific factors, such as sterile broth, supernatant fluids of coagulase-negative strains, and ammonium sulfate precipitates of culture supernatant fluids of various staphylococci. Immune sera with a high agglutinating titer for staphylococcal cells do not prevent growth of serum-resistant strains; serum-susceptible strains are inhibited as in normal serum control. Activation or blocking of the serum fibrinolytic system does not influence serum bacteriostatic activity. The growth rate of serum-resistant strains is identical in serum and in Todd-Hewitt broth; serum-susceptible strains are inhibited to the inoculum level, but decreases and increases in viable count are noted during a 24-hr observation period. Observations made with sera of 10 animal species clearly demonstrated differences in serum bacteriostatic activity, mouse serum being completely noninhibitory and cat serum only weakly inhibitory. The technique of quantitative determination of serum susceptibility of staphylococci is described, and the importance of serum antistaphylococcal activity in vitro is discussed. Experimental staphylococcal infection produced in rabbits by intravenous injection of different Staphylococcus aureus strains did not result in significant changes in serum antistaphylococcal activity. The technique of experimental infection used caused chronic infection, with a peak on the 14th day; this was proved by means of a newly developed 5'-nucleotidase test. At the same time, sera of infected animals exhibited slight inhibitory properties, which returned to initial values 1 week later. Infection was produced by strains recognized as nonpathogenic and was inhibited in vitro by sera from both normal and infected rabbits. It is concluded that antistaphylococcal activity of serum should be considered as an "in vitro" phenomenon, which seems to have no importance in defense mechanisms of rabbits infected intravenously with staphylococci.
D000818:Animals; D000900:Anti-Bacterial Agents; D001434:Bacteriophage Typing; D001769:Blood; D001770:Blood Bactericidal Activity; D002415:Cats; D003030:Coagulase / Q000378:metabolism / Q000494:pharmacology; D004285:Dogs; D005342:Fibrinolysis; D006168:Guinea Pigs; D006460:Hemolysin Proteins; D006736:Horses; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D066298:In Vitro Techniques; D051379:Mice; D009708:Nucleotidases; D011200:Poultry; D011817:Rabbits; D051381:Rats; D012756:Sheep; D013203:Staphylococcal Infections; D013210:Staphylococcus
D000900:Anti-Bacterial Agents; D003030:Coagulase; D006460:Hemolysin Proteins; D007106:Immune Sera; D009708:Nucleotidases